NEU 2.46% $15.83 neuren pharmaceuticals limited

Share Price, page-11132

  1. 135 Posts.
    lightbulb Created with Sketch. 124
    I agree. You are correct when you analyse what we have.

    I don't think there is any chance of a really big number in a takeover, that scenario is in a perfect world with a perfect buyer and everything going to plan but I do hold some optimism the potential of 2591 will mean whoever puts a bid in will pay a bit more than expected. So, on balance, it would equal a Reata number, maybe slightly lower, maybe, slightly higher.

    If a Reata number is 85AUD, who would not take between $60 and $100 before a phase 3 trial placebo-controlled trial? I expect a lower-end number to test Neuren's self-belief before the real negotiating starts.

    The risk-reward for Neuren leads me to believe this zone of offer would be acceptable to them. If 2591 is that good, someone will offer a figure between these numbers after the FDA meeting and disclosure of the new indications.

    I think this scenario would leave both seller and buyer content.

    Gone by Xmas.

    Just my thoughts.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$15.83
Change
-0.400(2.46%)
Mkt cap ! $2.034B
Open High Low Value Volume
$16.33 $16.37 $15.82 $6.459M 403.7K

Buyers (Bids)

No. Vol. Price($)
12 863 $15.82
 

Sellers (Offers)

Price($) Vol. No.
$15.84 396 9
View Market Depth
Last trade - 14.07pm 13/08/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.